{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T03:49:02Z","timestamp":1747194542700,"version":"3.40.5"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T00:00:00Z","timestamp":1593993600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Blood culture-negative endocarditis (BCNE) is diagnosed in 2\u20137% of patients with infective endocarditis (IE) and recent antibiotic use is a known risk factor. Altered mental status may be a presenting symptom. Besides empiric antibiotics, intravenous anticoagulation using heparin may have a role in the management of such patients.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>A 23-year-old male patient was referred to our center with fever, altered mental status and abnormal gait. Neurologic examination revealed Wernicke\u2019s aphasia. Cardiac auscultation revealed systolic murmur at the left sternal border. ECG (electrocardiogram) was unremarkable. Brain MRI showed multiple cerebellar lesions. Transthoracic echocardiography (TTE) demonstrated three large masses on the right ventricle (RV), tricuspid valve (TV), and anterior mitral valve (MV) leaflet. Blood cultures (three sets) were negative. Intravenous heparin therapy was administered. After 48\u2009h, the second TTE demonstrated that one valvular lesion disappeared and the other two lesions showed a significant decrease in size. The patient\u2019s neurological symptoms resolved gradually. Further workup for collagen vascular disorders did not show any abnormality.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>BCNE should be considered in patients with fever and neurologic manifestations. TTE should be performed to detect valvular abnormalities. Intravenous heparin could be used in such patients when TTE demonstrate valvular vegetations.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12879-020-05206-0","type":"journal-article","created":{"date-parts":[[2020,7,6]],"date-time":"2020-07-06T12:03:44Z","timestamp":1594037024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Culture-negative endocarditis with neurologic presentations and dramatic response to heparin: a case report"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1632-0511","authenticated-orcid":false,"given":"Hossein","family":"Sheibani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad","family":"Salari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9903-3029","authenticated-orcid":false,"given":"Elham","family":"Azmoodeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4441-0688","authenticated-orcid":false,"given":"Amirhessam","family":"Kheirieh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Chaghazardi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,7,6]]},"reference":[{"issue":"47","key":"5206_CR1","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000008392","volume":"96","author":"PE Fournier","year":"2017","unstructured":"Fournier PE, Gouriet F, Casalta JP, et al. Blood culture-negative endocarditis: improving the diagnostic yield using new diagnostic tools. Medicine (Baltimore). 2017;96(47):e8392.","journal-title":"Medicine (Baltimore)"},{"key":"5206_CR2","doi-asserted-by":"crossref","unstructured":"Dilley JR, Clinch CR. Blood culture-negative endocarditis presenting as altered mental status. BMJ Case Rep 2018;2018:bcr-2018-224707.","DOI":"10.1136\/bcr-2018-224707"},{"issue":"1\u20132","key":"5206_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medmal.2014.11.003","volume":"45","author":"P Tattevin","year":"2015","unstructured":"Tattevin P, Watt G, Revest M, Arvieux C, Fournier PE. Update on blood culture-negative endocarditis. Med Mal Infect. 2015;45(1\u20132):1\u20138.","journal-title":"Med Mal Infect"},{"issue":"3","key":"5206_CR4","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1136\/heart.89.3.241","volume":"89","author":"CK Naber","year":"2003","unstructured":"Naber CK, Erbel R. Diagnosis of culture negative endocarditis: novel strategies to prove the suspect guilty. Heart. 2003;89(3):241\u20133.","journal-title":"Heart"},{"issue":"1","key":"5206_CR5","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/CMR.14.1.177-207.2001","volume":"14","author":"P Brouqui","year":"2001","unstructured":"Brouqui P, Raoult D. Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev. 2001;14(1):177\u2013207.","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"5206_CR6","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.athoracsur.2012.10.044","volume":"95","author":"A Katsouli","year":"2013","unstructured":"Katsouli A, Massad MG. Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg. 2013;95(4):1467\u201374.","journal-title":"Ann Thorac Surg"},{"issue":"44","key":"5206_CR7","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","volume":"36","author":"G Habib","year":"2015","unstructured":"Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC guidelines for the management of infective endocarditis: the task force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J. 2015;36(44):3075\u2013128.","journal-title":"Eur Heart J"},{"issue":"1","key":"5206_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1093\/jac\/dkw362","volume":"72","author":"E Menu","year":"2017","unstructured":"Menu E, Gouriet F, Casalta JP, et al. Evaluation of empirical treatment for blood culture-negative endocarditis. J Antimicrob Chemother. 2017;72(1):290\u20138.","journal-title":"J Antimicrob Chemother"},{"issue":"7","key":"5206_CR9","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1136\/jcp.2009.064311","volume":"62","author":"D Jain","year":"2009","unstructured":"Jain D, Halushka MK. Cardiac pathology of systemic lupus erythematosus. J Clin Pathol. 2009;62(7):584\u201392.","journal-title":"J Clin Pathol"},{"issue":"23","key":"5206_CR10","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1161\/CIRCULATIONAHA.112.000813","volume":"127","author":"E Garcia-Cabrera","year":"2013","unstructured":"Garcia-Cabrera E, Fernandez-Hidalgo N, Almirante B, et al. Neurological complications of infective endocarditis: risk factors, outcome, and impact of cardiac surgery: a multicenter observational study. Circulation. 2013;127(23):2272\u201384.","journal-title":"Circulation"},{"issue":"11","key":"5206_CR11","doi-asserted-by":"publisher","first-page":"3056","DOI":"10.1161\/STROKEAHA.113.001470","volume":"44","author":"B Iung","year":"2013","unstructured":"Iung B, Tubiana S, Klein I, et al. Determinants of cerebral lesions in endocarditis on systematic cerebral magnetic resonance imaging: a prospective study. Stroke. 2013;44(11):3056\u201362.","journal-title":"Stroke"},{"issue":"1","key":"5206_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1136\/practneurol-2016-001469","volume":"17","author":"E Jiad","year":"2017","unstructured":"Jiad E, Gill SK, Krutikov M, et al. When the heart rules the head: ischaemic stroke and intracerebral haemorrhage complicating infective endocarditis. Pract Neurol. 2017;17(1):28\u201334.","journal-title":"Pract Neurol"},{"issue":"4","key":"5206_CR13","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1183\/09031936.00164714","volume":"45","author":"G Agnelli","year":"2015","unstructured":"Agnelli G, Becattini C. Anticoagulant treatment for acute pulmonary embolism: a pathophysiology-based clinical approach. Eur Respir J. 2015;45(4):1142\u20139.","journal-title":"Eur Respir J"},{"issue":"7","key":"5206_CR14","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1056\/NEJM199708143370702","volume":"337","author":"M Cohen","year":"1997","unstructured":"Cohen M, Demers C, Gurfinkel EP, et al. A comparison of low-molecular-weight heparin with unfractionated heparin for unstable coronary artery disease. Efficacy and safety of subcutaneous enoxaparin in non-Q-wave coronary events study group. N Engl J Med. 1997;337(7):447\u201352.","journal-title":"N Engl J Med"},{"issue":"3","key":"5206_CR15","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1056\/NEJM197501162920307","volume":"292","author":"RD Rosenberg","year":"1975","unstructured":"Rosenberg RD. Actions and interactions of antithrombin and heparin. N Engl J Med. 1975;292(3):146\u201351.","journal-title":"N Engl J Med"},{"issue":"5","key":"5206_CR16","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1002\/ccr3.556","volume":"4","author":"AH Preston","year":"2016","unstructured":"Preston AH, Williams S, Archer J. A review of the role of anticoagulation for patients with infective endocarditis and embolic stroke. Clin Case Rep. 2016;4(5):513\u20136.","journal-title":"Clin Case Rep"},{"issue":"4","key":"5206_CR17","doi-asserted-by":"publisher","first-page":"e229909","DOI":"10.1136\/bcr-2019-229909","volume":"12","author":"T Kitano","year":"2019","unstructured":"Kitano T, Sengoku K, Itotagawa E, Todo K. Dynamic morphological changes in Libman-sacks endocarditis under different anticoagulation regimens. BMJ Case Rep. 2019;12(4):e229909.","journal-title":"BMJ Case Rep"},{"key":"5206_CR18","doi-asserted-by":"crossref","unstructured":"Jennings R, Hammersley D, Hancock J, Blauth C. The diagnostic and therapeutic challenges of infective endocarditis presenting as acute stroke. BMJ Case Rep 2017;2017.","DOI":"10.1136\/bcr-2017-219762"},{"issue":"3","key":"5206_CR19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1016\/j.amjmed.2019.07.059","volume":"133","author":"KA Davis","year":"2020","unstructured":"Davis KA, Huang G, Petty SA, Tan WA, Malaver D, Peacock JE Jr. The effect of preexisting anticoagulation on cerebrovascular events in left-sided infective endocarditis. Am J Med. 2020;133(3):360\u20139.","journal-title":"Am J Med"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-020-05206-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-020-05206-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T23:16:17Z","timestamp":1625526977000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-020-05206-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,6]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["5206"],"URL":"https:\/\/doi.org\/10.1186\/s12879-020-05206-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"type":"electronic","value":"1471-2334"}],"subject":[],"published":{"date-parts":[[2020,7,6]]},"assertion":[{"value":"28 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report. The consent can be made available upon request.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"476"}}